Effect of gliclazide on prostaglandin and thromboxane synthesis in guinea-pig platelets

This publication has 16 references indexed in Scilit:

• 1-phenyl-3-pyrazolidone: An inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets
  Prostaglandins, 1978
• Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide
  Current Medical Research and Opinion, 1978
• Thromboxane synthetase inhibitors as pharmacological tools: Differential biochemical and biological effects on platelet suspensions
  Prostaglandins, 1977
• Cyclic adenosine 3′,5′-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets
  Biochemical and Biophysical Research Communications, 1977
• Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
  Journal of Clinical Investigation, 1977
• The importance of phospholipase-A2 in prostaglandin biosynthesis
  Biochemical Pharmacology, 1976
• Collagen suspension for platelet aggregation test
  Blood & Vessel, 1976
• Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase
  Thrombosis Research, 1975
• Prevention of Experimental Obstructions in the Retinal Microcirculation
  Ophthalmologica, 1975
• Effets “in vitro” du gliclazide, nouvel agent hypoglycemiant, sur les plaquettes humaines normales
  Thrombosis Research, 1974